BCYC Q3 2019 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$360M

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$614,000-61.9% YoY

Gross Profit

-$5M-889.9% margin

Operating Income

-$10M-1669.9% margin

Net Income

-$9M-1544.3% margin

EPS (Diluted)

$-0.53

QoQ Revenue Growth

-59.7%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$819,000

Balance Sheet

Total Assets

$116M

Total Liabilities

$21M

Stockholders' Equity

$95M

Cash & Equivalents

$96M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$614,000	$2M	-61.9%
Gross Profit	-$5M	-$4M	-35.5%
Operating Income	-$10M	-$6M	-61.3%
Net Income	-$9M	-$8M	-23.3%